STOCK TITAN

[Form 4] Columbia Seligman Premium Technology Growth Fund, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Christopher O. Petersen, reported on Form 4 a sale of 139.078 shares of Columbia Seligman Premium Technology Growth Fund, Inc. (STK) on 09/04/2025 at a reported price of $31.91 per share. The filing shows 0 shares beneficially owned following the reported transaction. The Form 4 was signed by power of attorney on 09/08/2025. The report lists Petersen's role as SVP & Assistant Secretary and indicates officer/director relationship to the issuer.

Christopher O. Petersen ha dichiarato nel Modulo 4 la vendita di 139.078 azioni di Columbia Seligman Premium Technology Growth Fund, Inc. (STK) in data 04/09/2025 al prezzo riportato di $31.91 per azione. Dopo l'operazione il deposito indica la detenzione di 0 azioni. Il Modulo 4 è stato firmato con procura il 08/09/2025. Il rapporto riporta la qualifica di Petersen come SVP & Assistant Secretary e segnala il suo rapporto di ufficiale/direttore con l'emittente.

Christopher O. Petersen informó en el Formulario 4 la venta de 139.078 acciones de Columbia Seligman Premium Technology Growth Fund, Inc. (STK) el 04/09/2025 a un precio declarado de $31.91 por acción. Tras la transacción declarada, el informe muestra la tenencia de 0 acciones. El Formulario 4 fue firmado por poder el 08/09/2025. El reporte indica que Petersen ocupa el puesto de SVP & Assistant Secretary y señala su relación de oficial/miembro del consejo con el emisor.

Christopher O. Petersen는 Form 4에 Columbia Seligman Premium Technology Growth Fund, Inc.(STK) 139,078주2025-09-04에 주당 $31.91로 매도했다고 신고했습니다. 신고된 거래 이후 보유 주식은 0주로 기재되어 있습니다. Form 4는 2025-09-08에 위임장으로 서명되었습니다. 보고서에는 Petersen의 직책을 SVP & Assistant Secretary로 기재하고 발행사와의 임원/이사 관계를 표시하고 있습니다.

Christopher O. Petersen a déclaré sur le Formulaire 4 la vente de 139 078 actions de Columbia Seligman Premium Technology Growth Fund, Inc. (STK) le 04/09/2025 au prix déclaré de 31,91 $ par action. Le dépôt indique la détention de 0 actions après la transaction rapportée. Le Formulaire 4 a été signé par procuration le 08/09/2025. Le rapport mentionne le rôle de Petersen en tant que SVP & Assistant Secretary et précise sa relation d'officier/directeur avec l'émetteur.

Christopher O. Petersen meldete in Formular 4 den Verkauf von 139.078 Anteilen der Columbia Seligman Premium Technology Growth Fund, Inc. (STK) am 04.09.2025 zu einem angegebenen Preis von $31,91 je Aktie. Nach der gemeldeten Transaktion werden 0 Aktien begünstigt gehalten. Das Formular 4 wurde am 08.09.2025 per Vollmacht unterzeichnet. Der Bericht nennt Petersens Funktion als SVP & Assistant Secretary und weist auf die Beziehung als Offizier/Director zum Emittenten hin.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Insider sale of 139.078 shares at $31.91 reduced reported beneficial ownership to zero; transaction appears routine and limited in scale.

The filing documents a single non-derivative sale by Christopher O. Petersen on 09/04/2025 for 139.078 shares at $31.91 per share. The report shows no remaining beneficial ownership after the sale. From a trading-impact perspective, the disclosure records a straightforward disposition; the filing does not include context such as total prior holdings or reason for sale, so material implications cannot be assessed from this form alone.

TL;DR: An officer/director reported a small-scale disposition; the Form 4 meets disclosure requirements but provides limited governance insight.

The Form 4 identifies Petersen as SVP & Assistant Secretary and marks officer/director relationship. The sale reduces his reported beneficial ownership to zero as disclosed. The form is properly executed via power of attorney. No additional governance issues, such as related-party transactions or plan-based sales, are disclosed in this filing.

Christopher O. Petersen ha dichiarato nel Modulo 4 la vendita di 139.078 azioni di Columbia Seligman Premium Technology Growth Fund, Inc. (STK) in data 04/09/2025 al prezzo riportato di $31.91 per azione. Dopo l'operazione il deposito indica la detenzione di 0 azioni. Il Modulo 4 è stato firmato con procura il 08/09/2025. Il rapporto riporta la qualifica di Petersen come SVP & Assistant Secretary e segnala il suo rapporto di ufficiale/direttore con l'emittente.

Christopher O. Petersen informó en el Formulario 4 la venta de 139.078 acciones de Columbia Seligman Premium Technology Growth Fund, Inc. (STK) el 04/09/2025 a un precio declarado de $31.91 por acción. Tras la transacción declarada, el informe muestra la tenencia de 0 acciones. El Formulario 4 fue firmado por poder el 08/09/2025. El reporte indica que Petersen ocupa el puesto de SVP & Assistant Secretary y señala su relación de oficial/miembro del consejo con el emisor.

Christopher O. Petersen는 Form 4에 Columbia Seligman Premium Technology Growth Fund, Inc.(STK) 139,078주2025-09-04에 주당 $31.91로 매도했다고 신고했습니다. 신고된 거래 이후 보유 주식은 0주로 기재되어 있습니다. Form 4는 2025-09-08에 위임장으로 서명되었습니다. 보고서에는 Petersen의 직책을 SVP & Assistant Secretary로 기재하고 발행사와의 임원/이사 관계를 표시하고 있습니다.

Christopher O. Petersen a déclaré sur le Formulaire 4 la vente de 139 078 actions de Columbia Seligman Premium Technology Growth Fund, Inc. (STK) le 04/09/2025 au prix déclaré de 31,91 $ par action. Le dépôt indique la détention de 0 actions après la transaction rapportée. Le Formulaire 4 a été signé par procuration le 08/09/2025. Le rapport mentionne le rôle de Petersen en tant que SVP & Assistant Secretary et précise sa relation d'officier/directeur avec l'émetteur.

Christopher O. Petersen meldete in Formular 4 den Verkauf von 139.078 Anteilen der Columbia Seligman Premium Technology Growth Fund, Inc. (STK) am 04.09.2025 zu einem angegebenen Preis von $31,91 je Aktie. Nach der gemeldeten Transaktion werden 0 Aktien begünstigt gehalten. Das Formular 4 wurde am 08.09.2025 per Vollmacht unterzeichnet. Der Bericht nennt Petersens Funktion als SVP & Assistant Secretary und weist auf die Beziehung als Offizier/Director zum Emittenten hin.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Petersen Christopher O.

(Last) (First) (Middle)
901 3RD AVE S

(Street)
MINNEAPOLIS MN 55402

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Columbia Seligman Premium Technology Growth Fund, Inc. [ STK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP & Asst Secretary
3. Date of Earliest Transaction (Month/Day/Year)
09/04/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Columbia Seligman Premium Technology Growth Fund, Inc. 09/04/2025 S 139.078 D $31.91 0 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
/s/ Joseph D'Alessandro, Power of Attorney 09/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Columbia Seligman Premium Tech Growth

NYSE:STK

STK Rankings

STK Latest News

STK Latest SEC Filings

STK Stock Data

603.28M
17.27M
14.52%
0.03%
Asset Management
Financial Services
Link
United States
Boston